Atrial Fibrillation Clinical Trials

A randomized, open-label, comparative study for Edoxaban and Enoxaparin/Warfarin vs Warfarin alone in subjects with Atrial Fibrillation who have undergone Electrical Cardioversion

The purpose of this study is to compare edoxaban with warfarin to see if it is safe and effective in preventing thromboembolism (formation of a clot [thrombus] in a blood vessel that breaks loose and is carried by the blood stream to block another vessel) and strokes which results when …

Early diagnosis of transthyretin cardiac amyloidosis

Our goal of the study is to identify African American (AA) patients who are carrying the V122I ATTR mutation with mild left ventricular hypertrophy and other patients who might have wild type ATTR (senile amyloidosis) who presented with carpal tunnel syndrome for surgical intervention, or lone atrial fibrillations, or other …

Evaluation of QDOT MICRO catheter for pulmonary vein isolation (PVI) in subjects with Paroxysmal Atrial Fibrillation (PAF)

The purpose of this study is to demonstrate the safety and 12-Month effectiveness of the QDOT MICRO catheter when used with the nMARQ RF generator in the treatment of drug refractory symptomatic paroxysmal atrial fibrillation (PAF) during standard electrophysiology mapping and RF ablation procedures.

First Line Radiofrequency Ablation Versus Antiarrhythmic Drugs for Persistent Atrial Fibrillation Treatment: the RAAFT-3 Trial

To determine if catheter-based atrial fibrillation (AF) ablation is superior to treatment with antiarrhythmic drugs as a first-line therapy for symptomatic persistent AF

Efficacy of DE-MRI-Guided Fibrosis Ablation vs. Conventional Catheter Ablation of Atrial Fibrillation: The DECAAF II Study

You are being asked to participate in this study because you have atrial fibrillation and are planning to undergo an ablation procedure to treat this heart rhythm irregularity.

None

None

None

None

None